2.4700
+0.1500
+(6.47%)
At close: January 31 at 4:00:02 PM EST
2.3900
-0.08
(-3.24%)
After hours: January 31 at 6:23:47 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALLEN JIM L Director | Stock Award(Grant) | Sep 3, 2024 | 109,673 |
ALTMAN PETER Chief Executive Officer | Purchase | Jan 30, 2025 | 107,320 |
BLANK ANDREW SCOTT Director | Stock Award(Grant) | Sep 3, 2024 | -- |
FROST PHILLIP MD ET AL Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 19, 2024 | -- |
GILLIS EDWARD M Officer | Sale | Dec 20, 2024 | 8,968 |
MCCLUNG DAVID Chief Financial Officer | Stock Award(Grant) | Oct 11, 2024 | 30,008 |
STERTZER SIMON H Director | Stock Award(Grant) | Jun 23, 2023 | 1,489,750 |
Related Tickers
LIXT Lixte Biotechnology Holdings, Inc.
2.4700
+1.02%
SABS SAB Biotherapeutics, Inc.
2.1900
+0.92%
NLSP NLS Pharmaceutics AG
2.4900
+25.76%
OKYO OKYO Pharma Limited
1.0600
-3.64%
DRMA Dermata Therapeutics, Inc.
1.2300
+2.50%
NERV Minerva Neurosciences, Inc.
2.3100
-2.94%
PLRZ Polyrizon Ltd.
1.1500
-12.88%
BPTH Bio-Path Holdings, Inc.
0.8074
-1.04%
DOMH Dominari Holdings Inc.
3.4900
-2.51%
IMRN Immuron Limited
2.0420
-4.58%